Vitamin D3

Generic Name: Vitamin D3

Brand Names: Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₄O

CAS Number: 67-97-0

Unique Ingredient Identifier: 1C6V77QF41

Background: Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalcifero...

Indication: Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .
...

Associated Conditions: Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture

Associated Therapies: Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Clinical Trials

Vitamin D Treatment in Patients With Chronic Hepatitis C

Not Applicable

Conditions: Chronic Hepatitis C

Interventions: Drug: Adding vitamin D
Drug: Vitamin D

First Posted Date: 2008-12-09

Last Posted Date: 2008-12-09

Lead Sponsor: Hillel Yaffe Medical Center

Registration Number: NCT00804752

Locations: 🇮🇱
Hillel Yaffe Medical Center, Hadera, Israel

20070360 Incident Dialysis

Phase 4

Completed

Conditions: Secondary Hyperparathyroidism
Chronic Kidney Disease

Interventions: Drug: Cinacalcet
Drug: Vitamin D

First Posted Date: 2008-12-05

Last Posted Date: 2018-10-17

Lead Sponsor: Amgen

Target Recruit Count: 313

Registration Number: NCT00803712

Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

Phase 2

Completed

Conditions: Psoriasis
Atopic Dermatitis

Interventions: Drug: Placebo
Drug: Vitamin D3

First Posted Date: 2008-11-13

Last Posted Date: 2017-04-12

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 82

Registration Number: NCT00789880

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
National Jewish Health, Denver, Colorado, United States

Vitamin D in Active Tuberculosis (TB) Study

Not Applicable

Withdrawn

Conditions: Tuberculosis

Interventions: Drug: Placebo
Drug: Vitamin D3

First Posted Date: 2008-11-10

Last Posted Date: 2012-01-20

Lead Sponsor: Atlanta VA Medical Center

Registration Number: NCT00788320

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model

Early Phase 1

Completed

Conditions: Gingivitis

Interventions: Other: Placebo
Drug: vitamin D3

First Posted Date: 2008-10-24

Last Posted Date: 2017-10-02

Lead Sponsor: Boston University

Target Recruit Count: 35

Registration Number: NCT00779909

Locations: 🇺🇸
Boston University Goldman School of Dental Medicine, Boston, Massachusetts, United States

Vitamin D Repletion in Chronic Kidney Disease

Early Phase 1

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: Vitamin D3

First Posted Date: 2008-10-15

Last Posted Date: 2015-01-15

Lead Sponsor: Rockefeller University

Target Recruit Count: 12

Registration Number: NCT00772772

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients

Phase 3

Conditions: Kidney Transplantation
Vitamin D Deficiency
Renal Osteodystrophy

Interventions: Drug: Placebo
Drug: Cholecalciferol

First Posted Date: 2008-09-15

Last Posted Date: 2014-01-22

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 200

Registration Number: NCT00752401

Locations: 🇦🇹
Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis, Vienna, Austria

Vitamin D, Insulin Resistance, and Cardiovascular Disease

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Hypertension
Insulin Resistance
Type 2 Diabetes Mellitus
Cardiovascular Disease

Interventions: Drug: Placebo
Drug: Vitamin D3

First Posted Date: 2008-08-18

Last Posted Date: 2020-02-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 125

Registration Number: NCT00736632

Locations: 🇺🇸
Washington Universiy, Saint Louis, Missouri, United States

Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)

Phase 3

Completed

Conditions: Osteoporosis

Interventions: Drug: Placebo
Drug: Odanacatib
Drug: Vitamin D3
Drug: Calcium supplement

First Posted Date: 2008-08-07

Last Posted Date: 2018-08-27

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 214

Registration Number: NCT00729183

Vitamin D for Painful Nocturnal Leg Cramps

Not Applicable

Terminated

Conditions: Leg Cramps, Nocturnal

Interventions: Drug: placebo
Drug: vitamin d

First Posted Date: 2008-07-15

Last Posted Date: 2019-09-17

Lead Sponsor: University of Wisconsin, Madison

Target Recruit Count: 29

Registration Number: NCT00715429

Locations: 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy